Keller, D. N., Medwid, S. J., Ross, C. D., Wigle, T. J., & Kim, R. B. (2023). Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenetics and genomics, 33(1), 10. https://doi.org/10.1097/FPC.0000000000000486
Chicago Style (17th ed.) CitationKeller, Denise N., Samantha J. Medwid, Cameron D. Ross, Theodore J. Wigle, and Richard B. Kim. "Impact of Organic Anion Transporting Polypeptide, P-glycoprotein, and Breast Cancer Resistance Protein Transporters on Observed Tamoxifen and Endoxifen Concentration and Adverse Effects." Pharmacogenetics and Genomics 33, no. 1 (2023): 10. https://doi.org/10.1097/FPC.0000000000000486.
MLA (9th ed.) CitationKeller, Denise N., et al. "Impact of Organic Anion Transporting Polypeptide, P-glycoprotein, and Breast Cancer Resistance Protein Transporters on Observed Tamoxifen and Endoxifen Concentration and Adverse Effects." Pharmacogenetics and Genomics, vol. 33, no. 1, 2023, p. 10, https://doi.org/10.1097/FPC.0000000000000486.